|

Metabolomics in the Diagnosis and Treatment of Asthma in Children

RECRUITINGSponsored by I.M. Sechenov First Moscow State Medical University
Actively Recruiting
SponsorI.M. Sechenov First Moscow State Medical University
Started2024-03-13
Est. completion2026-06
Eligibility
Age12 Years – 17 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07280364

Summary

The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is: • Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.

Eligibility

Age: 12 Years – 17 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age from 12 to 17 years old
* Confirmed diagnosis of asthma
* Informed voluntary consent to participate in the study

Exclusion Criteria:

* age under 12 years
* no established diagnosis of asthma
* concomitant severe somatic, metabolic, and endocrine diseases
* patient's withdrawal of informed consent

Conditions1

Asthma

Browse More Trials

Asthma trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.